Drug regulator approves SII's Covishield and Bharat Biotech's Covaxin for restrictive use in emergency situation

The subject expert committee had given conditional nod to both the vaccines and these were awaiting the drug regulator's approval.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3pFMuBZ
via IFTTT